Discussions

Roots Analysis recently published a report on the global Cybersecurity Insurance Market growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories.

Owing to the rise in demand for biologics, service providers and drug innovators are upgrading their technical expertise to efficiently manufacture high quality products using continuous manufacturing techniques.
The global continuous manufacturing market size is estimated to be worth USD 2,080 million in 2023 and anticipated to grow at a CAGR of 6.4% during the forecast period.
Competitive landscape of small molecule continuous manufacturing companies. The small molecule continuous manufacturing companies landscape features close to 50 manufacturers having expertise in end to end continuous manufacturing or semi continuous manufacturing of drug products.
The market landscape is well-fragmented, featuring the presence of small, mid-sized, large, and very large companies, which claim to have the required expertise in continuous small molecule API manufacturing and Finished Dosage Form (FDF) manufacturing. It is interesting to highlight that majority (>80%) of the small molecule manufacturers are focused on commercial manufacturing. Further, more than 75% of the continuous small molecule manufacturers provide contract manufacturing services for manufacturing of small molecule APIs / intermediates / FDFs.
Majority of the partnerships (59%) were inked between players based in same regions (intracontinental deals). It is worth highlighting that in the current scenario, companies headquartered in North America are actively investing in consolidating their indigenous presence by seeking collaborations in this domain.
Owing to the increasing adoption of continuous manufacturing system, several players in continuous manufacturing market have made significant investments in order to expand their existing facilities or establish new production plants. It is worth highlighting that over 40% of the expansions have been inked since 2021. Majority of the expansions reported in this market were focused on the expansion of existing capacity. Notably, most of the deals were focused on small molecule continuous manufacturing (~60%) followed by continuous manufacturing of biologics. Some examples of firms involved in expansion initiatives for small molecule drugs include (in alphabetical order) Ajinomoto OmniChem, Axplora, CONTINUUS Pharmaceuticals, Hovione and Kaneka. Most (60%) of the instances were focused on manufacturing of APIs followed by FDFs and intermediates. Further, close to 50% of the expansions were primarily carried out by players based in Europe, followed by players based in North America. As such, the continuous manufacturing companies in other regions are also expected to continue to carry out capacity expansions, driving the market growth for continuous manufacturing market.
Several non-profit organizations have extended financial support to aid the efforts of players engaged in continuous manufacturing. Grants worth over USD 45 million, disbursed across 65+ instances, have been awarded for research related to continuous manufacturing. There has been a constant influx of investments in this domain by various non-profit organizations. This can be attributed to the increasing adoption of continuous manufacturing by the industry players, which is likely to encourage different non-profit organizations, such as the NIH, to fund diverse initiatives undertaken by various stakeholders.; notably, grants worth around USD 20 million were awarded in 2021 alone. Post-2020, over 30 grants were awarded by the NIH. Further, only a few grants (3%) have been awarded for a period of more than five years, while grants worth over USD 43 million have been awarded of up to five years. It is worth noting that engineering department emerged as the most popular department having received maximum number of grants in this domain.

A personal statement is your chance to stand out in college applications. It allows admissions officers to understand who you are beyond grades and test scores. A strong personal statement reflects your personality, goals, and academic passion while demonstrating why you are a great fit for the program.

Roots Analysis recently published a report on the global Deep Learning Market growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories.